Document Detail

Local perspective on a rare brain tumour: adult medulloblastoma.
MedLine Citation:
PMID:  23279053     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Little contemporary data are available regarding Australian patterns of care in adult medulloblastoma. It is unclear whether treatment, extrapolated from paediatric protocols despite known differences between the two groups, results in comparable efficacy.
AIM: To perform a retrospective review of patterns of care in adult medulloblastoma, especially with respect to adjuvant chemotherapy, in Australian patients.
METHODS: All medulloblastoma patients aged 15 years or older at two neuro-oncology institutions were identified from January 1995-May 2011. Patients with supratentorial or peripheral tumours were excluded. Standardised data were extracted from each institution regarding symptoms, disease staging, treatments received, toxicities and survival outcomes.
RESULTS: Seventeen eligible patients were identified. Median age was 37 years (range 20-67 years). All had good performance status (Eastern Cooperative Oncology Group 0-1). There were 11 standard-risk de novo patients, three high-risk de novo patients and three patients with recurrent disease. Median overall survival (OS) had not been reached for standard-risk patients with median follow up of 58 months. The median OS for high-risk de novo patients was 21 months, while the median OS was 15 months for patients with recurrent disease. Treatment was well tolerated, with haematological toxicities being most common.
CONCLUSIONS: Combined modality therapy (surgery followed by postoperative radiotherapy and adjuvant chemotherapy) was well tolerated and associated with good outcomes in standard-risk de novo patients. High-risk and recurrent disease patients do extremely poorly regardless of treatment and better treatment strategies are needed in these patients.
S F Wong; G Mak; M A Rosenthal; L Cher; H K Gan
Related Documents :
24062403 - Prognostic relevance of treatment response measured by flow cytometric residual disease...
17436593 - Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic a...
25331073 - Mthfr-1298 a>c (rs1801131) is a predictor of survival in two cohorts of stage ii/iii co...
Publication Detail:
Type:  Journal Article; Multicenter Study; Review    
Journal Detail:
Title:  Internal medicine journal     Volume:  43     ISSN:  1445-5994     ISO Abbreviation:  Intern Med J     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-05-14     Completed Date:  2014-02-19     Revised Date:  2014-03-31    
Medline Journal Info:
Nlm Unique ID:  101092952     Medline TA:  Intern Med J     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  567-72     Citation Subset:  IM    
Copyright Information:
© 2012 The Authors; Internal Medicine Journal © 2012 Royal Australasian College of Physicians.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Brain Neoplasms / diagnosis*,  mortality,  therapy*
Chemotherapy, Adjuvant / methods
Cohort Studies
Combined Modality Therapy / methods
Follow-Up Studies
Medulloblastoma / diagnosis*,  mortality,  therapy*
Middle Aged
Radiotherapy, Adjuvant / methods
Retrospective Studies
Survival Rate / trends
Young Adult
Comment In:
Intern Med J. 2014 Feb;44(2):209-10   [PMID:  24528821 ]
Intern Med J. 2014 Feb;44(2):210-1   [PMID:  24528822 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Study on the factors determining home death of patients during home care: A historical cohort study ...
Next Document:  Compliance to the CONSORT statement of randomized controlled trials in solid organ transplantation: ...